Tilray Hosts Official Ribbon-Cutting Ceremony At European Union Campus For Medical Cannabis Production and Distribution

Tilray Ribbon Cutting Portugal

The 250,000 square-foot facility located in Cantanhede, Portugal serves as the hub for Tilray’s cultivation, processing, distribution and research of medical cannabis products in Europe CANADA: Tilray, a global pioneer in the research, cultivation, production and distribution of cannabis today celebrated the official opening of its European Union (EU) Campus located in Cantanhede, Portugal. Tilray CEO Read the full article…

FSD Pharma Receives Cannabis Sales License From Health Canada

FSD Pharma

CANADA: FSD Pharma Inc. announced that its wholly-owned subsidiary FV Pharma Inc. has received its Sale for Medical Purposes license to sell cannabis under the Cannabis Act (Canada). The license went into effect on April 18, 2019. The license allows the current FSD facility to supply and sell cannabis products. The company anticipates receiving the amended sales license that will include the sale of dried and fresh cannabis flower in Read the full article…

iCAN Secures Financing Through A Convertible Loan Of CAD $4 million (US $3 million)

l to r. Jesse Kaplan, Plaza Capital, Sruli Weinreb, Plaza Capital, Saul Kaye, CEO, iCAN: Israel-Cannabis.signing the agreement.

ISRAEL: iCAN: Israel-Cannabis has announced that it has issued a secured convertible loan in the amount of CAD $4,000,000 to a group of investors led by Plaza Capital. The principal amount of each Convertible Security, plus accrued interest shall be convertible, for no additional consideration, into common shares of the Company at the option of the holders at Read the full article…

Tilray Expands Manufacturing Capacity With New Processing License From Health Canada

tilray

Newly-acquired Natura Naturals Inc. located in Leamington, Ontario obtains processing license, allowing it to produce a wide range of cannabis form factors for the Canadian market CANADA: Natura Naturals Inc., a wholly-owned subsidiary of Tilray, Inc. and High Park Holdings Ltd., has received a standard processing license under the Cannabis Act. The Natura greenhouse facility, which Read the full article…

Aphria Receives Health Canada License Amendment, Approving Fully Expanded Production At Aphria One

Aphria

CANADA: Aphria has announced that Health Canada has granted the Company its license amendment, permitting Aphria to commence production in an additional 800,000 square feet of facilities at its Aphria One location, as part of the Company’s completed Part IV and Part V expansions. “This is a major milestone for Aphria on its path to becoming a Read the full article…

Investors That Purchased FSD Pharma Securities May Have An Opportunity To Recover Their Financial Losses.

MJLegal

CANADA: Morganti & Co., P.C., a cross border shareholder’s rights law firm, has commenced a shareholder class action lawsuit against FSD Pharma Inc. for publishing investor documents containing misrepresentations of material fact about the status of its joint venture with Auxly Cannabis Group Inc. between September 29, 2018, and January 7 or February 6, 2019. The shareholders Read the full article…

International Hemp Oil Company, Functional Remedies, Acquires New Lab, Increasing Production Capacity Ten-Fold

International Hemp Oil

COLORADO: Functional Remedies, vertically integrated manufacturer of whole-plant hemp oil products, announced a major expansion of its lab and production facility from 2,000 square feet to a new 25,000-square-foot facility located in Louisville, CO to meet the rapidly growing demand for its products across the U.S. and globally. Additionally, Functional Remedies recently moved into new 4,000-square-foot Read the full article…

Tilray Increases Cannabis Supply With Acquisition Of Natura Naturals Holdings

Natura Canada

CANADA: Tilray, a global leader in cannabis research, cultivation, production and distribution, announced the closing of a previously announced definitive agreement to acquire all of the issued and outstanding securities of Natura Naturals Holdings, the parent company of a licensed cultivator of cannabis. Moving forward, the Natura facility will operate under the name High Park Read the full article…

WHO Expert Committee Calls For Changes In Cannabis’ International Classification

who-logo1

SWITZERLAND: Members of the World Health Organization (WHO) Expert Committee on Drug Dependence have proposed amending the classification of cannabis under international law. According to reporting in the British Medical Journal, the WHO policy reversal “takes account of the growing evidence for the medical applications of the drug,” and marks the first time that the agency has reviewed its Read the full article…

Global Science & Business Leaders Converge For Panama’s First Medical Cannabis Conference February 12-13, 2019

CannaTech

ISRAEL: The world’s leading cannabis researchers and scientists, ag-tech, pharma experts, regulators, investors, and entrepreneurs will share their knowledge about the burgeoning medical cannabis industry at CannaTech Panama, Panama’s first ever international Summit for Accelerating Medical Cannabis Innovation. The main event will take place February 12-13, 2019 at the Central Hotel in Casco Viejo. According to Saul Read the full article…